Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 10

Results For "Q2"

264 News Found

Max Healthcare Institute reports Q2 FY24 consolidated PAT at Rs. 276.68 Cr
News | November 07, 2023

Max Healthcare Institute reports Q2 FY24 consolidated PAT at Rs. 276.68 Cr

Max Healthcare Institute has reported total income of Rs. 1408.64 crores during the period ended September 30, 2023


Divis Laboratories posts Q2 FY24 consolidated PAT at Rs. 348 Cr
News | November 07, 2023

Divis Laboratories posts Q2 FY24 consolidated PAT at Rs. 348 Cr

Divi's Laboratories Limited has reported total income of Rs. 1995 crores during the period ended September 30, 2023


Zydus Wellness consolidated Q2 FY24 PAT drops to Rs. 5.9 Cr
News | November 07, 2023

Zydus Wellness consolidated Q2 FY24 PAT drops to Rs. 5.9 Cr

Zydus Wellness has reported total income of Rs. 444 crores during the period ended September 30, 2023


Metropolis Healthcare reports Q2 FY24 consolidated PAT at Rs. 35.45 Cr
News | November 06, 2023

Metropolis Healthcare reports Q2 FY24 consolidated PAT at Rs. 35.45 Cr

Metropolis Healthcare has reported total income of Rs. 309.71 crores during the period ended September 30, 2023


Orchid Pharma consolidated Q2 FY24 net profit up at Rs. 19.80 Cr
News | November 06, 2023

Orchid Pharma consolidated Q2 FY24 net profit up at Rs. 19.80 Cr

Orchid Pharma reported total income of Rs. 207.11 crores during the period ended September 30, 2023


Themis Medicare posts Q2 FY24 PAT at Rs. 11.31 Cr
News | November 06, 2023

Themis Medicare posts Q2 FY24 PAT at Rs. 11.31 Cr

The company has reported total income of Rs. 107.22 crores during the period ended September 30, 2023


Poly Medicure posts consolidated Q2 FY24 PAT at Rs. 62.18 Cr
News | November 06, 2023

Poly Medicure posts consolidated Q2 FY24 PAT at Rs. 62.18 Cr

Poly Medicure has reported total income of Rs. 351.38 crores during the period ended September 30, 2023


Tatva Chintan Pharma Chem reports Q2 FY24 consolidated PAT at Rs. 7.78 Cr
News | November 04, 2023

Tatva Chintan Pharma Chem reports Q2 FY24 consolidated PAT at Rs. 7.78 Cr

Tatva Chintan Pharma Chem has reported total income of Rs. 97.42 crores during the period ended September 30, 2023


Lyka Labs posts Q2 FY24 loss at Rs. 48.65 lakhs
News | November 03, 2023

Lyka Labs posts Q2 FY24 loss at Rs. 48.65 lakhs

Lyka Labs has reported total income of Rs. 28.23 crores during the period ended September 30, 2023


Morepen Laboratories posts Q2 FY24 consolidated PAT at Rs. 21.25 Cr
News | November 03, 2023

Morepen Laboratories posts Q2 FY24 consolidated PAT at Rs. 21.25 Cr

Morepen Laboratories has reported total income of Rs. 425 crores during the quarter ended September 30, 2023